XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Nov. 01, 2025
Oct. 26, 2024
Operating activities    
Net (loss) income $ (84,473,000) $ 28,709,000
Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities:    
Depreciation and amortization 148,327,000 17,854,000
Gain from equity method investments (2,983,000) (1,055,000)
Amortization of debt issuance costs 9,054,000 1,047,000
Provision for credit losses 1,978,000 (67,000)
Reserve for inventory excess and obsolescence 2,679,000 2,032,000
Other non-cash expense, net 2,089,000 1,194,000
Non-cash lease expense 12,655,000 4,980,000
Loss on foreign currency transactions 215,000 32,000
Unrealized (gain) loss on available-for-sale equity securities, net (8,858,000) 267,000
Stock-based compensation 19,995,000 10,137,000
Loss on disposal of property and equipment 594,000 201,000
Amortization of debt securities (201,000)  
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (51,519,000) (3,500,000)
Unbilled receivables and retentions (124,147,000) (4,684,000)
Inventories (49,360,000) 7,485,000
Income taxes receivable (22,230,000) (9,636,000)
Prepaid expenses and other assets (12,747,000) (2,247,000)
Accounts payable (7,772,000) (7,624,000)
Other liabilities (2,106,000) (20,416,000)
Net cash (used in) provided by operating activities (168,810,000) 24,709,000
Investing activities    
Acquisition of property and equipment (33,537,000) (10,447,000)
Contributions in equity method investments (2,123,000) (1,183,000)
Purchase of available-for-sale investments (264,215,000)  
Acquisition of capitalized software to be sold (13,266,000)  
Business acquisitions, net of cash acquired (844,580,000)  
Net cash used in investing activities (1,157,721,000) (11,630,000)
Financing activities    
Proceeds from shares issued, net of underwriter costs 968,515,000  
Proceeds from convertible debt, net of underwriter costs 726,944,000  
Payment of debt issuance costs (2,445,000) (900,000)
Payment of equity issuance costs (1,388,000)  
Tax withholding payment related to net settlement of equity awards (10,900,000) (4,064,000)
Employee stock purchase plan contributions 2,467,000  
Exercise of stock options   506,000
Other (9,000) (13,000)
Net cash provided by (used in) financing activities 1,645,325,000 (17,471,000)
Effects of currency translation on cash and cash equivalents (222,000) 51,000
Net increase (decrease) in cash and cash equivalents 318,572,000 (4,341,000)
Cash and cash equivalents at beginning of period 40,862,000 73,301,000
Cash and cash equivalents at end of period 359,434,000 68,960,000
Cash paid, net during the period for:    
Income taxes 3,192,000 14,444,000
Interest 12,216,000 777,000
Non-cash activities    
Issuance of common stock for business acquisition 2,640,365,000  
Unrealized loss on available-for-sale investments, net of deferred tax expense of $0 for the three and six months ended November 1, 2025 and October 26, 2024, respectively (184,000)  
Change in foreign currency translation adjustments 476,000 364,000
Acquisitions of property and equipment included in accounts payable 5,625,000 964,000
Term loan    
Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities:    
Amortization of debt issuance costs 6,668,000  
Financing activities    
Principal payments of term loan (700,000,000) (28,000,000)
Proceeds from long-term debt 693,202,000 $ 15,000,000
Revolving credit facility    
Financing activities    
Principal payments of revolver (265,000,000)  
Proceeds from revolver, net of creditor costs $ 233,939,000